A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the long-term safety and efficacy of oxymetazoline hydrogen chloride
(HCL) Cream 1.0% (AGN-199201) in patients with persistent erythema associated with rosacea.